logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Antonio Llombart‐Cussac

Hospital Arnau de Vilanova

59H指数
697论文数
1.6W被引数
收录论文 212
发表时间
logo
Trop-2 overexpression as a prognostic marker in early triple-negative breast cancer: results from the GEICAM_CIBOMA trialTrop-2过表达作为早期三阴性乳腺癌的预后标志物：GEICAM_CIBOMA试验的结果
errBreast Cancer Research
IF5.6
err2026-08-28
err0
errOAAI
errFederico Rojo; Sara Lopez-Tarruella; Begoña Bermejo; Laura Torrecillas; Manuel Ruiz-Borrego; Jose Bines; Jose G. M. Segalla; Jose A. Garcia-Saenz; Roberto Torres; Juan de la Haba-Rodriguez; Elena Garcia-Martinez; Henry Gomez; Antonio Llombart-Cussac; Maria Rodriguez de la Borbolla; Laura Perez Michel; Margarita Amenedo; Isaura Fernandez; Alvaro Rodriguez-Lescure; Jesus Cardenas; Jeferson Vinholes; Eduardo Martinez de Dueñas; Vega Iranzo Gonzalez-Cruz; Miguel Angel Segui; Sandra Perez-Buira; Jesus Herranz; Raul Rincon; Rosalia Caballero; Carlos H. Barrios; Miguel Martin; Angel Guerrero-Zotano
err分享
err收藏
Modulation of the response to immunotherapy in triple-negative breast cancer: the role of the microbiota and microbial metabolites in the tumor microenvironment三阴性乳腺癌对免疫治疗的反应调控：肿瘤微环境中微生物群和微生物代谢物的角色
errGut Microbes
IF11
err2026-07-08
err0
errOAAI
errLucía Serrano-García; Elisabeth Martínez-Salvador; Ana Belda-Marco; Clara Herrero-Oliva; Javier Cortés; Antonio Llombart-Cussac; Leonor Fernández-Murga
err分享
err收藏
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer: Updated Efficacy Results from the phase 3 EMBER-3 trialImlunestrant与或不与Abemaciclib联用治疗晚期乳腺癌：来自Ⅲ期EMBER-3试验的更新疗效结果
errAnnals of Oncology
IF65.4
err2025-12-12
err0
errOAAI
errK.L. Jhaveri; P. Neven; M.L. Casalnuovo; S-B. Kim; E. Tokunaga; P. Aftimos; C. Saura; J. O’Shaughnessy; N. Harbeck; L.A. Carey; G. Curigliano; J. Watanabe; E. Lim; J. Huang; Z. Qingyuan; A. Llombart-Cussac; C. Huang; B. Desai; Y. Limay; X.A. Wang
err分享
err收藏
Comparing [18F]FDG–positron emission tomography and breast magnetic resonance imaging to predict pathological complete response and 3-year invasive disease-free survival in HER2-positive early breast cancer patients: an unplanned exploratory analysis of the PHERGain trial☆比较[18F]FDG-正电子发射断层扫描与乳腺磁共振成像预测HER2阳性早期乳腺癌患者病理完全缓解和3年侵袭性无病生存率的比较：PHERGain试验的非计划探索性分析☆
errESMO Open
IF8.3
err2025-11-06
err0
errOAAI
errJ.J. García-Mosquera; J.M. Pérez-García; M. Ruiz-Borrego; A. Stradella; B. Bermejo; S. Escrivá-de-Romaní; L. Calvo Martínez; G. Gebhart; K. Kerrou; M. Gion; G. Antonarelli; S. Santasusagna Canal; J. Rodríguez-Morato; L. Mina; M. Sampayo-Cordero; A. Llombart-Cussac; J. Cortés
err分享
err收藏
The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)血浆中大规模基因测序（NGS）对晚期非小细胞肺癌（NSCLC）患者治疗方案选择的影响
errCancers 2025, Vol. 17, Page 3469
IF4.4
err2025-10-29
err0
errOAAI
errPaula Llor-Rodriguez; Ana Blasco-Cordellat; Sonia Macia-Escalante; Leonor Fernández-Murga; José Vidal-Martinez; Javier Garde-Noguera; José García-Sánchez; Antonio Llombart-Cussac
err分享
err收藏
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial帕他单抗德鲁克替康（HER3-DXd）在活动性脑转移的非小细胞肺癌患者中的应用（TUXEDO-3）：一项多中心、单臂、II期临床试验
errThe Lancet Oncology
IF0
err2025-10-27
err0
PREAI
errThorsten Fuereder; Javier Garde-Noguera; Juan José García-Mosquera; Manuel Ruiz-Borrego; María Valero; Antonio Llombart-Cussac; María Gion; Richard Greil; Miriam Arumi; Marta Campolier; José Antonio Guerrero; Giulia Raimondi; Mario Mancino; Carlos Jiménez-Cortegana; Marta Vaz-Batista; Felicitas Oberndorfer; Maximilian Marhold; Anna Sophie Berghoff; Julia Furtner; Rupert Bartsch; Matthias Preusser
err分享
err收藏
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial帕他妥昔德鲁克特肯（HER3-DXd）在活动性脑转移的乳腺癌患者中的应用（TUXEDO-3）：一项多中心、单臂、II期临床试验
errThe Lancet Oncology
IF0
err2025-10-27
err0
PREAI
errRupert Bartsch; Maximilian Marhold; Javier Garde-Noguera; María Gion; Manuel Ruiz-Borrego; Richard Greil; María Valero; Antonio Llombart-Cussac; Juan José García-Mosquera; Miriam Arumi; Javier Cortés; Marta Campolier; José Antonio Guerrero; Felipe Slebe; Elena Martínez-García; Carlos Jiménez-Cortegana; Marta Vaz-Batista; Felicitas Oberndorfer; Julia Furtner; Thorsten Fuereder; Anna Sophie Berghoff; Matthias Preusser
err分享
err收藏
Corrigendum to “Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3”勘误：“Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3”
errAnnals of Oncology
IF65.4
err2025-10-15
err0
errOAAI
errM.P. Goetz; M. Toi; J. Huober; J. Sohn; O. Trédan; I.H. Park; M. Campone; S.-C. Chen; L.M. Manso; S. Paluch-Shimon; O.C. Freedman; J. O’Shaughnessy; X. Pivot; S.M. Tolaney; S.A. Hurvitz; A. Llombart-Cussac; V. André; A. Saha; G. van Hal; A. Shahir; H. Iwata; S.R.D. Johnston
err分享
err收藏
Immunogenicity of SARS-CoV-2 mRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational StudySARS-CoV-2 mRNA疫苗在乳腺癌接受积极治疗患者中的免疫原性：一项前瞻性观察研究
errPathogens 2025, Vol. 14, Page 947
IF3.3
err2025-09-30
err0
errOAAI
errMaría Leonor Fernández-Murga; Lucía Serrano-García; Giuseppe D’Auria; María Portero Hernández; Llúcia Martínez-Priego; Loreto Ferrús-Abad; Griselda de Marco; María Victoria Domínguez-Márquez; Antonio Llombart-Cussac
err分享
err收藏
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysisHER2DX和早期HER2阳性乳腺癌的生存结局：一项基于个体患者水平的荟萃分析
errlancet oncology
IF0
err2025-07-14
err0
PREAI
errGuillermo Villacampa; Tomás Pascual; Paolo Tarantino; Javier Cortés; José Perez-García; Antonio Llombart-Cussac; Pierfranco Conte; Mario Mancino; Valentina Guarneri; Maria Vittoria Dieci; Adrienne G Waks; Francesco Schettini; Fara Brasó-Maristany; Gaia Griguolo; Beatriz Alonso de Castro; Cristina Reboredo; Silvia Antolín; Coralia Bueno-Muiño; Isabel Echavarría; Sara López-Tarruella; Tatiana Massarrah; María del Monte-Millán; Miguel Martín; Wesley Buckingham; Joel S Parker; Ana Vivancos; Kornelia Polyak; Otto Metzger Filho; Antonio C Wolff; Angela DeMichele; Nadine M Tung; Charles M Perou; Laia Paré; Patricia Villagrasa; Aleix Prat; Sara M Tolaney
err分享
err收藏
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial预防曲拉鲁单抗govitecan相关中性粒细胞减少症和腹泻在HER2阴性晚期乳腺癌患者中的效果（PRIMED）：一项开放标签、单臂、Ⅱ期临床试验
erreClinicalMedicine
IF10
err2025-07-01
err0
PREAI
errJosé Manuel Pérez-García; María Gion; Manuel Ruiz-Borrego; Isabel Blancas; Elena López-Miranda; Salvador Blanch; Sabela Recalde; Cristina Reboredo Rendo; Xavier González; Nerea Ancizar; Serafin Morales; Patricia Cortez; Zuzanna Piwowarska; Eileen Shimizu; José Antonio Guerrero; Miguel Sampayo-Cordero; Alejandro Martínez-Bueno; Javier Cortés; Antonio Llombart-Cussac
err分享
err收藏
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial☆在PARSIFAL试验中，对内分泌敏感、激素受体阳性/HER2阴性晚期乳腺癌患者使用palbociclib联合fulvestrant或letrozole的延长随访研究☆
errESMO Open
IF8.3
err2025-07-01
err0
PREAI
errA. Llombart-Cussac; J.M. Pérez-García; M. Bellet; F. Dalenc; M. Gil-Gil; M. Ruiz-Borrego; J. Gavila; P. Schmid; P. Zamora; D. Wheatley; E. Martínez-de Dueñas; K. Amillano; S. Di Cosimo; A. Anton; P. Cottu; E. Shimizu; M. Fernandez; M. Sampayo-Cordero; J. Cortés
err分享
err收藏
Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial来自PARSIFAL试验的激素受体阳性晚期乳腺癌中palbociclib反应的生物标志物
errnpj Breast Cancer
IF7.6
err2025-06-20
err0
errOAAI
errJoan Albanell; Angelo Gámez Pozo; Carlos L. Arteaga; Meritxell Bellet; Federico Rojo; Abel González; Beatriz Bellosillo; Violeta Serra; Petra Gener; José Antonio Guerrero; Eileen Shimizu; Mario Mancino; Jose Rodríguez-Morató; Leonardo Mina; José Manuel Pérez-García; Javier Cortés; Antonio Llombart-Cussac
err分享
err收藏
Advancing breast cancer therapy in the era of molecular diagnostics分子诊断时代下乳腺癌疗法的进展
errbreast
IF0
err2025-05-08
err0
errOAAI
errMaria Grazia Carnevale; Riccardo Ray Colciago; Maria Carmen De Santis; Laura Cortesi; Cinzia De Marco; Antonio Marra; Andrea Vingiani; Franco Nolè; Giuseppe Curigliano; Giancarlo Pruneri; Antonio Llombart-Cussac; Serena Di Cosimo; Javier Cortes
err分享
err收藏
Gene Expression Signatures for Guiding Initial Therapy in ER+/HER2-Early Breast CancerER+/HER2-早期乳腺癌初始治疗的基因表达谱指导
errCANCERS
IF4.4
err2025-04-28
err0
errOAAI
errMarin-Liebana, Sara; Llor, Paula; Serrano-Garcia, Lucia; Fernandez-Murga, Maria Leonor; Comes-Raga, Ana; Torregrosa, Dolores; Perez-Garcia, Jose Manuel; Cortes, Javier; Llombart-Cussac, Antonio
err分享
err收藏
Decreased gene expression of interleukin 2 receptor subunit γ (CD132) in tissues of patients with Crohn's disease
errWORLD JOURNAL OF GASTROENTEROLOGY
IF5.4
err2025-03-28
err1
PREAI
errAndreu-Ballester, Juan Carlos; Hurtado-Marcos, Carolina; Garcia-Ballesteros, Carlos; Perez-Griera, Jaime; Izquierdo, Fernando; Ollero, Dolores; Jimenez, Ana; Gil-Borras, Rafael; Llombart-Cussac, Antonio; Lopez-Chulia, Francisca; Cuellar, Carmen
err分享
err收藏
Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence ( jan , 10.1007/s11523-024-01125-1 , 2025)
errTARGETED ONCOLOGY
IF4
err2025-03-01
err0
errOAAI
errGarcia-Saenz, Jose angel; Rodriguez-Lescure, Alvaro; Cruz, Josefina; Albanell, Joan; Alba, Emilio; Llombart, Antonio
err分享
err收藏
Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence
errTARGETED ONCOLOGY
IF4
err2025-01-13
err1
PREAI
errGarcia-Saenz, Jose angel; Rodriguez-Lescure, Alvaro; Cruz, Josefina; Albanell, Joan; Alba, Emilio; Llombart, Antonio
err分享
err收藏
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis曲妥珠单抗deruxtecan治疗HER2-positive乳腺癌活动性脑转移的三项研究的患者水平汇总分析结果
errESMO OPEN
IF8.3
err2025-01-01
err0
errOAAI
errBartsch, R.; Perez-Garcia, J. M.; Furtner, J.; Berghoff, A. S.; Marhold, M.; Starzer, A. M.; Hughes, M.; Kabraji, S.; Sammons, S.; Anders, C.; Murthy, R. K.; Swearingen, A. E. D. Van; Pereslete, A.; Gion, M.; Batista, M. Vaz; Braga, S.; Pinto, P. B. C.; Sampayo-Cordero, M.; Llombart-Cussac, A.; Preusser, M.; Cortes, J.; Lin, N. U.
err分享
err收藏
Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review三阴性乳腺癌的免疫逃避模式和新的潜在治疗靶点: 综述
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2024-12-13
err0
errOAAI
errSerrano Garcia, Lucia; Javega, Beatriz; Llombart Cussac, Antonio; Gion, Maria; Perez-Garcia, Jose Manuel; Cortes, Javier; Fernandez-Murga, Maria Leonor
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
C
Charles M. Perou
H 指数: 193 · 论文数: 2.0K
J
Jörge E. Cortes
H 指数: 179 · 论文数: 3.6K
J
Jorge S. Reis‐Filho
H 指数: 153 · 论文数: 1.5K
F
Fabrice André
H 指数: 148 · 论文数: 1.8K
J
Josep Tabernero
H 指数: 146 · 论文数: 2.7K
查看更多